Trametinib

Trametinib 

To Order Contact us: caitlyn@ucb-bioproducts.com

Trametinib (GSK1120212)

A3018-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

A3018-50 50 mg
EUR 161
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

A3018-500 500 mg
EUR 519
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (GSK1120212)

A3018-S Evaluation Sample
EUR 81
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-10 10 mg
EUR 108
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-100 100 mg
EUR 187
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib DMSO solvate

A3887-50 50 mg
EUR 142
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase.

Trametinib (DMSO solvate)

HY-10999A 100mg
EUR 214

Trametinib